Parikh Mihir S, Seeley Eric, Nguyen-Tran Evelyn, Krishna Ganesh
*Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA †Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco ‡El Camino Hospital, Mountain View, CA.
J Bronchology Interv Pulmonol. 2017 Oct;24(4):330-333. doi: 10.1097/LBR.0000000000000383.
Surgical treatment with lung resection has traditionally been the treatment of choice for pulmonary cavities containing aspergillomas that cause hemoptysis. Endobronchial ultrasound (EBUS) is a minimally invasive bronchoscopic technique that is commonly used for transbronchial needle aspiration of hilar and mediastinal lymph nodes as well as centrally located parenchymal lesions. Here, we describe a case of a 71-year-old woman who was found to have a cavitary lesion in the lung containing aspergillomas. Under direct ultrasound visualization with EBUS, liposomal amphotericin B was injected into the aspergillomas. These aspergillomas regressed after treatment. To our knowledge, this is the first reported treatment of aspergilloma with EBUS-guided transbronchial needle injection of liposomal amphotericin B.
传统上,对于导致咯血的肺曲菌球性肺空洞,肺切除术一直是首选的治疗方法。支气管内超声(EBUS)是一种微创支气管镜技术,常用于经支气管针吸活检肺门和纵隔淋巴结以及位于中央的实质性病变。在此,我们描述一例71岁女性,其肺部发现有空洞性病变,内有曲菌球。在EBUS直接超声引导下,将脂质体两性霉素B注入曲菌球。治疗后这些曲菌球消退。据我们所知,这是首例关于EBUS引导经支气管针注射脂质体两性霉素B治疗曲菌球的报道。